# Optimal Detection of Atrial Fibrillation in TIA

Study · id `cardio:ct-nct04075500` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04075500](<https://clinicaltrials.gov/study/NCT04075500>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04075500

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 516 participants.

## Technical summary

Registry record NCT04075500. Randomized; single masking; primary purpose diagnostic. Start 2019-03-12 (actual); primary completion 2024-03-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 516 participants (enrolled count; ClinicalTrials.gov record NCT04075500, source copy `cardio:ctgov-nct04075500-2026-02-09`, retrieved 2026-10-26)
- Started: 2019-03-12 (actual) (ClinicalTrials.gov record NCT04075500, source copy `cardio:ctgov-nct04075500-2026-02-09`, retrieved 2026-10-26)
- Primary completion: 2024-03-15 (actual) (ClinicalTrials.gov record NCT04075500, source copy `cardio:ctgov-nct04075500-2026-02-09`, retrieved 2026-10-26)
- Completion: 2025-08-31 (actual) (ClinicalTrials.gov record NCT04075500, source copy `cardio:ctgov-nct04075500-2026-02-09`, retrieved 2026-10-26)
- Countries: Germany; Spain (ClinicalTrials.gov record NCT04075500, source copy `cardio:ctgov-nct04075500-2026-02-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04075500-2026-02-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimal Detection of Atrial Fibrillation in TIA
- Acronym: ODEA-TIA
- Condition: Atrial Fibrillation
- Condition: Transient Ischemic Attack
- Intervention (Device): Subcutaneously implanted event recorder (REVEAL LINQ)
- Intervention (Device): 28-day non-invasive continuous ECG monitoring (patch)
- Lead sponsor: Alfried Krupp Krankenhaus
- Lead sponsor class: OTHER
- Collaborator: Medtronic Bakken Research
- Collaborator class: INDUSTRY
- Collaborator: Coordinating Centre for Clinical Trials Heidelberg
- Collaborator class: UNKNOWN
- Collaborator: Wuerzburg University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry lists this organization as the lead sponsor: Alfried Krupp Krankenhaus (`cardio:org-alfried-krupp-krankenhaus`)
- Registry lists this organization as a collaborator: Wuerzburg University Hospital (`cardio:org-wuerzburg-university-hospital`)

## Provenance

Content hash: 81790c30b0b1e2b42cc95ffebc59123294dc5ee02496022832a91dd54e666112
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
